Alzheimer's, dementia care to cost U.S. $200 billion this year
March 8, 2012 in Alzheimer's disease & dementia
Alzheimer's Association projects continued increases in payments as baby boomers age.
(HealthDay) -- Caring for people with Alzheimer's disease and other types of dementia will cost the United States about $200 billion this year, a total that includes $140 billion paid by Medicare and Medicaid, new statistics released Thursday show.
Medicaid payments are 19 times higher for seniors with Alzheimer's and other dementias and Medicare payments for the conditions are nearly three times higher, compared to payments for other patients, according to the "2012 Alzheimer's Disease Facts and Figures" report from the Alzheimer's Association.
Nearly 30 percent of people with Alzheimer's and other dementias are covered by both Medicare and Medicaid, compared to 11 percent of people without the conditions. This means that Medicare and Medicaid costs associated with Alzheimer's and other dementias will continue to rise as baby boomers age, the report said.
"Alzheimer's is already a crisis, and it's growing worse with every year," Harry Johns, president and CEO of the Alzheimer's Association, said in an association news release.
"While lives affected and care costs soar, the cost of doing nothing is far greater than acting now. Alzheimer's is a tremendous cost-driver for families and for Medicare and Medicaid. This crisis simply cannot be allowed to reach its maximum scale because it will overwhelm an already overburdened system," Johns added.
Most people with Alzheimer's and other dementias have at least one other serious chronic health problem, and Alzheimer's acts as a "cost multiplier" on these other diseases, according to the report.
For example, the statistics showed a senior with diabetes and Alzheimer's costs Medicare 81 percent more than a senior with diabetes alone. And a senior with cancer and Alzheimer's costs Medicare 53 percent more than a senior with cancer alone.
Mental impairment in patients with Alzheimer's and other dementias complicates the management of care, resulting in more and longer hospital stays, the authors noted in the news release.
"This disease must be addressed on parallel tracks: supporting research to find treatments that cure, delay or prevent the disease, and offering assistance and support to the more than 5 million Americans now living with Alzheimer's and their more than 15 million caregivers," Johns said.
"This is what the National Alzheimer's Plan is all about. Caring for people with Alzheimer's and other dementias costs America $200 billion in just one year. By committing just 1 percent of that cost, $2 billion, to research, it could begin to put the nation on a path to effective treatments and, ultimately, a cure," he noted.
The report also said that 800,000 people with Alzheimer's -- one out of seven -- live alone, and that up to half of them do not have an identifiable caregiver. That puts them at increased risk for such health problems as missed or delayed diagnosis, malnutrition and untreated medical conditions. They're also at increased risk for wandering away from home unattended and for accidental death.
Alzheimer's patients who live alone tend to be older, female and have lower levels of cognitive (memory and thinking) impairment, the report noted. However, they still face major challenges in performing daily tasks such as managing money and medications, shopping and preparing meals.
"Advance planning is important for everyone, particularly for individuals who have Alzheimer's or other dementias; but for the population that has Alzheimer's and lives alone, future planning is absolutely critical," Beth Kallmyer, vice president of constituent services for the Alzheimer's Association, said in the news release.
According to the association, an estimated 5.4 million people have Alzheimer's disease, and 15.2 million of their friends and family members provide 17.4 billion hours of unpaid care.
More information: The U.S. National Institute of Neurological Disorders and Stroke has more about Alzheimer's disease
Copyright © 2012 HealthDay. All rights reserved.
-
Alzheimer's cost triple that of other elderly
Mar 24, 2009 |
not rated yet |
0
-
US drafts plan to fight feared Alzheimer's disease
Feb 22, 2012 |
not rated yet |
0
-
Early-onset Alzheimer's not always associated with memory loss
May 19, 2011 |
not rated yet |
0
-
Obama to seek more Alzheimer's research money
Feb 07, 2012 |
not rated yet |
0
-
Alzheimer's disease to quadruple worldwide by 2050
Jun 10, 2007 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Lagrangian of object with air resistance
34 minutes ago
-
Does electromagnetic waves are generated by dc current?
47 minutes ago
-
Please check what's in the Ulaby book regarding reflection.
5 hours ago
-
Question in reflection and transmission at oblique incidence.
9 hours ago
-
Is this plasma (picture in thread)
9 hours ago
-
Basic physics understanding. Could someone explain?
11 hours ago
- More from Physics Forums - Classical Physics
More news stories
A new strategy required in the search for Alzheimer's drugs?
In the search for medication against Alzheimer's disease, scientists have focused – among other factors – on drugs that can break down Amyloid beta (A-beta). After all, it is the accumulation of A-beta that causes the ...
Alzheimer's disease & dementia
18 hours ago |
not rated yet |
0
Alzheimer's disease, the soft target of the euthanasia debate
(Medical Xpress)—The way Alzheimer's disease is portrayed by advocacy groups and the media is having undue influence on the euthanasia debate, according to a Deakin University nursing ethics professor.
Alzheimer's disease & dementia
19 hours ago |
not rated yet |
2
Scientists discover cinnamon compounds' potential ability to prevent Alzheimer's
Cinnamon: Can the red-brown spice with the unmistakable fragrance and variety of uses offer an important benefit? The common baking spice might hold the key to delaying the onset of –– or warding off ...
Alzheimer's disease & dementia
May 23, 2013 |
5 / 5 (5) |
0
|
Drug reverses Alzheimer's disease deficits in mice, research confirms
An anti-cancer drug reverses memory deficits in an Alzheimer's disease mouse model, University of Pittsburgh Graduate School of Public Health researchers confirm in the journal Science.
Alzheimer's disease & dementia
May 23, 2013 |
not rated yet |
0
|
Multiple research teams unable to confirm high-profile Alzheimer's study
Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.
Alzheimer's disease & dementia
May 23, 2013 |
3 / 5 (2) |
3
|
Engineered cytomegalovirus protects monkeys from HIV equivalent
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
Hormone levels may provide key to understanding psychological disorders in women
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
Going live: Immune cell activation in multiple sclerosis
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
Help at hand for people with schizophrenia
How can healthy people who hear voices help schizophrenics? Finding the answer for this is at the centre of research conducted at the University of Bergen.
Depression raises diabetics' risk of severe low blood sugar episodes
(Medical Xpress)—Patients with diabetes who are depressed are much more likely to develop episodes of dangerously low blood sugars, or hypoglycemia, than are those who are not depressed, a new study has ...